Logical Therapeutics Closes $16.9M C Round

Xconomy Boston — 

Logical Therapeutics, a developer of drugs for inflammatory conditions, says that it has closed a $16.9 million in a Series C round of funding, according to a press release. Xconomy reported last week that the Waltham, MA-based firm had raised $10 million of a planned $16.9 million round of financing, based on online records from the SEC. The company did not comment at the time, and it wasn’t clear from the records who invested in the financing. Now Logical says it’s closed on the full amount, and that SV Life Sciences led the round, which included investments from Burrill & Co., Novo A/S, and Novitas Capital.